COVICEPT THERAPEUTICS
CoviCept Therapeutics is focused on the development of a small molecule that inhibits the replication and spread of RNA viruses.
COVICEPT THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
2.3 M USD
Similar Organizations
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Castle Creek Biosciences
Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Orphion Therapeutics
Orphion Therapeutics is focused on the development of novel gene therapies for the treatment of rare and serious genetic disorders.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Employees Featured
Founder
Investors List
Forbion Capital Partners
Forbion Capital Partners investment in Seed Round - CoviCept Therapeutics
More informations about "CoviCept Therapeutics"
CoviCept Therapeutics 2025 Company Profile: …
CoviCept Therapeutics General Information Description. Developer of small molecule inhibitor of SARS-CoV-2 and other RNA viruses intended to create a direct therapeutic option to curb the COVID-19 pandemic.See details»
Covicept Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Jan 23, 2025 Explore Covicept Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, Drug:PJS-539. ... The statistics for drugs in the …See details»
CoviCept Therapeutics - VentureRadar
CoviCept Therapeutics, Inc. (“CoviCept”) is a California-based company that is developing a small molecule that inhibits the replication of SARS-CoV-2 (COVID-19) and other RNA viruses. …See details»
CoviCept Therapeutics - Funding, Financials, Valuation & Investors
CoviCept Therapeutics is focused on the development of a small molecule that inhibits the replication and spread of RNA viruses. Search Crunchbase. Start Free Trial . ... How much …See details»
CoviCept Therapeutics - Headquarter Location, Corporate Office …
CoviCept Therapeutics is Drug Discovery in United States that focus on RNA viruses business. Founded in 2020. They cover business area such as developer, small molecule inhibitor, …See details»
CoviCept Therapeutics - Contacts, Employees, Board Members, …
CoviCept Therapeutics is focused on the development of a small molecule that inhibits the replication and spread of RNA viruses. New. ... Experience the new Crunchbase, powered by …See details»
Forbion invests USD 2.3M in seed financing of CoviCept …
Jan 19, 2021 CoviCept Therapeutics, Inc. is a newly founded company based in San Diego, USA, focused on the development of a small molecule that inhibits the replication and spread …See details»
Covicept Therapeutics initiates a Phase 2 clinical study
Jun 10, 2021 San Diego, USA, October 6 th, 2021 – Covicept Therapeutics, an antiviral drug development company, announced today that a double-blind, placebo-controlled Phase 2 trial …See details»
CoviCept Therapeutics - Tech Company Profile - Gaebler.com …
CoviCept Therapeutics, Inc. is a newly founded company based in San Diego, USA, focused on the development of a small molecule that inhibits the replication and spread of RNA viruses, …See details»
CoviCept Therapeutics | CipherBio
Explore CoviCept Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Forbion Portfolio company Covicept Therapeutics initiates a Phase …
Oct 6, 2021 Naarden, The Netherlands, 6 October 2021 – Forbion, a leading European life sciences venture capital firm, today notes that portfolio company Covicept Therapeutics, Inc. …See details»
CoviCept Therapeutics - Updates, News, Events, Signals & Triggers
Jan 19, 2021 BioWorld Financial Watch — Covicept lands Forbion backing for mission to tackle RNA viruses Funding Round • Jan 19, 2021 CoviCept Therapeutics raised $2,300,000 / Seed …See details»
Covicept Therapeutics initiates a Phase 2 clinical study with PJS …
San Diego, USA, October 6 th, 2021 – Covicept Therapeutics, an antiviral drug development company, announced today that a double-blind, placebo-controlled Phase 2 trial of PSJ-539 …See details»
CoviCept Therapeutics Inc. - life-sciences-usa.com
Dec 17, 2020 Advertisement. Organisation › Details CoviCept Therapeutics Inc. CoviCept Therapeutics, Inc. is a newly founded company based in San Diego, USA, focused on the …See details»
Forbion invests USD 2.3M in seed financing of CoviCept …
Jan 19, 2021 Naarden, The Netherlands, and Munich, Germany, January 19 2021 – Forbion, a leading European life sciences venture capital firm, today announces a $2.3m seed …See details»
Covicept commences Phase II oral Covid-19 drug trial in Brazil
Oct 7, 2021 Covicept Therapeutics co-founder, chairman and CEO professor Sam Tsimikas: “It is a significant milestone for this programme to move into clinical development in less than a …See details»
Corcept's trial of ovarian cancer therapy shows PFS improvement
1 day ago The trial enrolled 381 platinum-resistant ovarian cancer subjects across sites in Argentina, Brazil, Canada, Europe, Australia, and South Korea. Credit: Chinnapong / …See details»
CoviCept Therapeutics - Crunchbase
CoviCept Therapeutics is focused on the development of a small molecule that inhibits the replication and spread of RNA viruses. Search Crunchbase. Start Free Trial . Chrome …See details»
Covicept Therapeutics Inc. - BioWorld
Feb 5, 2021 Covicept Therapeutics Inc., a young San Diego-based company focused on developing a small molecule to inhibit the replication and spread of SARS-CoV-2 and other …See details»
Covicept lands Forbion backing for mission to tackle RNA viruses
Feb 5, 2021 Covicept Therapeutics Inc., a young San Diego-based company focused on developing a small molecule to inhibit the replication and spread of SARS-CoV-2 and other …See details»